Officially launched in Spring 2024, the Institute of Translational Genomic Medicine’s (ITGM) mission is to advance world-class integrated genomic research and lead the MSM enterprise in promoting and developing the highest standards of ethical genomic research in underserved communities, tailored genomic platforms for diverse populations and accelerate the development of effective clinical tools to ameliorate health disparities.​

​ITGM provides expertise in next generation sequencing and bioinformatics for the research centers and institutes at Morehouse School of Medicine, partnering with researchers to analyze the genomes of African Americans and others throughout the African diaspora. The resulting genomic information is used to develop new diagnostic and treatment tools to fight disease disparities. In addition, ITGM provides genomic expertise and training through partnerships and collaborations with HBCUs nationally and other institutions around the world.